Zai Lab (ZLAB) Change in Account Payables (2020 - 2026)
Zai Lab (ZLAB) posted Change in Account Payables of $4.3 million for Q1 2026, down 79.06% sequentially from $20.4 million in Q4 2025, and up 56.65% YoY from $2.7 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Change in Account Payables (2020 - 2026) Analysis & Trends
Zai Lab has reported Change in Account Payables for 7 years, with the latest figure at $4.3 million in Q1 2026.
- Quarterly Change in Account Payables rose 56.65% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.5 million (up 54.65% YoY) and the FY2025 annual result came in at $19.9 million, up 1002.04% from the prior year.
- Change in Account Payables retreated to $4.3 million in Q1 2026 per ZLAB's latest filing, from $20.4 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $46.3 million in Q4 2023 and troughed at -$28.0 million in Q1 2022.
- A 5-year average of $294588.2 and a median of $2.7 million in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables tumbled 3988.69% in 2024, then soared 332.49% in 2025.
- Over 5 years, Change in Account Payables stood at -$24.9 million in 2022, then jumped by 285.76% to $46.3 million in 2023, then tumbled by 118.91% to -$8.8 million in 2024, then jumped by 332.49% to $20.4 million in 2025, then sank by 79.06% to $4.3 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $4.3 million, $20.4 million, and -$6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | -1.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.38 Mn |
| Mar 31, 2026 | 4.26 Mn |
| Dec 31, 2025 | 20.35 Mn |
| Sep 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | -8.75 Mn |
| Sep 30, 2024 | 12.66 Mn |
| Jun 30, 2024 | 7.25 Mn |
| Mar 31, 2024 | -13.37 Mn |
| Dec 31, 2023 | 46.30 Mn |
| Sep 30, 2023 | -12.53 Mn |
| Jun 30, 2023 | 3.36 Mn |
| Mar 31, 2023 | -327,000.00 |
| Dec 31, 2022 | -24.92 Mn |
| Sep 30, 2022 | -11.13 Mn |
| Jun 30, 2022 | 10.28 Mn |
| Mar 31, 2022 | -28.00 Mn |
| Dec 31, 2021 | 74.76 Mn |
| Sep 30, 2021 | -74.22 Mn |